XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma. Pelaia G, Jackson DJ, Nair P, Emmanuel B, et al. Chest 2025 Apr 19:S0012-3692(25)00441-6. doi: 10.1016/j.chest.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Pelaia G, Jackson DJ, Nair P, Emmanuel B, et al. XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma. Chest 2025 Apr 19:S0012-3692(25)00441-6. doi: 10.1016/j.chest.2025.
PMID: 40258512